➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Express Scripts
Johnson and Johnson
Harvard Business School
McKesson

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

CEFTAZIDIME SODIUM - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for ceftazidime sodium and what is the scope of freedom to operate?

Ceftazidime sodium is the generic ingredient in two branded drugs marketed by Baxter Hlthcare and Teligent, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for ceftazidime sodium.

Summary for CEFTAZIDIME SODIUM
Recent Clinical Trials for CEFTAZIDIME SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Zunyi Medical CollegeN/A
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Federal University of São PauloPhase 4

See all CEFTAZIDIME SODIUM clinical trials

US Patents and Regulatory Information for CEFTAZIDIME SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare CEFTAZIDIME SODIUM IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 063221-002 Apr 29, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
Teligent FORTAZ IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 050634-001 Apr 28, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
Teligent FORTAZ IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 050634-003 Apr 28, 1989 DISCN Yes No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare CEFTAZIDIME SODIUM IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 063221-001 Apr 29, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare CEFTAZIDIME SODIUM IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 063221-003 Apr 29, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Colorcon
Johnson and Johnson
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.